The Commons
Conversations featuring researchers, innovators, artists, entrepreneurs, community builders, and thought leaders who are improving the human condition in their own backyard and across the globe.
The Commons
Slamming Cancer: A Conversation with Steve Potts, CEO of SLAM BioTherapeutics
June 17, 2024
•
Wexford Science & Technology
•
Season 4
•
Episode 19
Commons host, Thomas Osha, catches up with serial entrepreneur, Steve Potts, to discuss his latest venture, SLAM BioTherapeutics. Slam Bio is developing a platform of first-in-class monoclonal antibody therapies and antibody-drug conjugates (ADCs) targeting cancer, beginning with blood cancers.
The conversation took place at the BIO International Conference 2024 in San Diego June 4-6, 2024.
https://slambio.com/